CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Pharma Mar SA Company Snapshot
Pharma Mar SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Mar SA with three other miscellaneous service companies in Europe: Galapagos NV of Belgium (2016 sales of 151.61 million Euro [US$185.57 million] of which 80% was R&D), AddLife AB of Sweden (1.98 billion Swedish Kronor [US$246.65 million] of which 63% was LabTech), and Bachem Holding AG which is based in Switzerland (236.48 million Swiss Francs [US$246.33 million] of which 89% was Active Pharmaceutical Ingredients).

Sales Analysis. During the year ended December of 2016, sales at Pharma Mar SA were 180.95 million Euro (US$221.48 million). This is a decrease of 6.6% versus 2015, when the company's sales were 193.82 million Euro. Contributing to the drop in overall sales was the 11.3% decline in Biotech Sector, from 125.45 million Euro to 111.29 million Euro. . However, these declines were partially offset by the increase in sales of Consumer Chemical Sector (up 3.4% to 69.66 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Pharma Mar SA
  Stock Performance Chart for Pharma Mar SA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 1.70
(Figures in Euro)
1 Week -36.2%   13 Weeks -31.7%  
4 Weeks -45.1%   52 Weeks -39.8%  
 
Pharma Mar SA Key Data:
  Ticker: PHM Country: Spain
  Exchanges: MAD Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 180,948,000
(Year Ending Jan 2017).
Employees: 713
  Currency: Euro Market Cap: 375,691,170
  Fiscal Yr Ends: December Shares Outstanding: 220,994,806
  Share Type: ACCION Closely Held Shares: 45,837,097
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.